A joint research by Chinese scientists has recently found that the oral nucleoside drug VV116, approved for the treatment of ...

The Nipah virus (NiV) is a zoonotic pathogen, meaning it is transmitted from animals to humans. It is known for causing severe respiratory illness and encephalitis. The World Health Organization (WHO) ...

Combination antiretroviral therapy (ART) has transformed HIV-1 infection into a chronic condition with near-normal life expectancy. For more than two decades, the standard regimen has been a ...

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with ...

A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and ...

Chinese researchers have demonstrated that the oral nucleoside drug VV116, which is already approved for treating Covid-19 in ...

As the Nipah cases in India raise worries across Asia, a new study by Chinese researchers has claimed that an existing oral ...

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...

A study in Emerging Microbes & Infections reports that VV116—an oral antiviral already approved for Covid-19 treatment in China and Uzbekistan—strongly inhibited Nipah virus strains in the lab and ...

Full abstracts will be released on February 4, 2026, at 7:00 am CET/1:00 am EST and will be available via the conference website here .

Switching to a 2-drug ART regimen was highly effective and well tolerated in virologically suppressed patients with HIV.